Effect of kyron T-134 and crospovidone as a fast disintegrating agent on formulation properties of fast dissolving tablet containing ketorolac and rizatriptan using direct compression method
DOI:
https://doi.org/10.15218/zjms.2024.21Keywords:
Ketorolac tromethamine, Rizatriptan benzoate, Direct compression method, Kyron T-134, Crospovidone, Fast Dissolving TabletAbstract
Background and objective: Fast dissolving tablets (FDTs) are "they are uncoated tablets that are supposed to be placed in the mouth and dispersed quickly before being swallowed" within minutes. This study aimed to formulate and evaluate a combination of ketorolac and rizatriptan as orally fast-dissolving tablets using the most common and easiest method to treat migraine attacks with or without aura. To investigate the effects of various types of diluents and super disintegrants on wetting time, water absorption ratio, disintegration, and dissolution time of combined drugs (ketorolac and rizatriptan) as oral dissolving tablets prepared by direct compression technique.
Methods: Pre-formulation experiments were carried out in order to rule out any physicochemical interactions between the two medications (ketorolac and rizatriptan) as well as between each drug and its excipients. Four different formulations of fast-dissolving tablets with different types and ratios of diluents and super disintegrants were created using the direct compression technique in order to improve the formulation. Organoleptic characteristics, weight variation, thickness, friability, hardness, disintegration duration, wetting duration, water absorption ratio, drug content, in-vitro dissolution, stability, and comparison tests have all been characterized.
Results: According to FT-IR, the two drugs and excipients exhibit no physicochemical interactions. The ideal formula F4 contains crospovidone and Kyron T-134 at optimal concentrations of 2.5% and 2.5%, respectively, and provides the majority of pharmaceutical drugs to be released within the first five minutes, a strong stability profile, the shortest wetting time with the fastest disintegration time (10 sec), and a pleasant flavor (strawberry flavoring agent).
Conclusion: Kyron T-134 with Crospovidone in a (1:1) ratio provided rapid disintegration. Ketorolac tromethamine and rizatriptan benzoate may be made into fast-dissolving oral tablets using Kyron T-134 and Crospovidone. Improving migraine compliance is a reasonable goal.
Metrics
References
Jena GK, Patra CN, Rahman M, Beg S. Recent Advances in the Development of Modified Release Oral Dosage Forms in Pharmaceutical Drug Product Development and Process Optimization. App Acad Press 2020; 1:79–96.
Schmidt K, Berding T, Kleine-Borgmann J, Engler H, Holle-Lee D, Gaul C, et al. The beneficial effect of positive treatment expectations on pharmacological migraine prophylaxis. Pain 2022; 163(2):19–27. 10.1097/j.pain.0000000000002341
Nurathirah MN, Yazid MB, Norhayati MN, Baharuddin KA, Abu Bakar MA. Efficacy of ketorolac in the treatment of acute migraine attack A systematic review and meta‐analysis. Acad Emerg Med 2022; 29(9):1118–31. https://doi.org/10.1111/acem.14457
Calandre EP, Slim M, Rico-Villademoros F. How does a physician decide which pharmacotherapeutic option to select for acute migraine attacks? Expert Opin Pharmacother. 2022; 23(10):1129–33. https://doi.org/10.1080/14656566.2022.2060740
Rada SK, Kumari A. Fast dissolving tablets waterless patient compliance dosage forms. J Drug Deliv Ther 2019; 9(1):303–17. https://doi.org/10.22270/jddt.v9i1.2292
Dave V, Yadav RB, Ahuja R, Yadav S. Formulation design and optimization of novel fast dissolving tablet of chlorpheniramine maleate by using lyophilization techniques. Bull Fac Pharm Cairo Univ 2017; 55(1):31–9. https://doi.org/10.1016/j.bfopcu.2016.12.001
Bindal R, Indurkhya A. Formulation and Evaluation of Ketorolac Tromethamine Mouth Dissolving Tablets. J Drug Deliv Ther 2021; 11(1):60–4. https://doi.org/10.22270/jddt.v11i1.4502
Al-dhahir RK, Al-kotaji M. Formulation of orally disintegration tablets of cinnarizine by using direct compression method. Int J Appl Pharm 2019; 11(1):117. http://dx.doi.org/10.22159/ijap.2019v11i1.29599
Jain AA, Barhate SD. Formulation Optimization and Evaluation of Mouth Dissolving Tablet of Rizatriptan Benzoate by using Natural Super disintegrant. Asian J Res Pharm Sci 2019; 9(4):245. 10.5958/2231-5659.2019.00038.9
Diener HC, Holle-Lee D, Nägel S, Dresler T, Gaul C, Göbel H, et al. Treatment of migraine attacks and prevention of migraine Guidelines by the German Migraine and Headache Society and the German Society of Neurology. Clin Transl Neurosci 2019; 3(1):2514183X1882337. https://doi.org/10.1177/2514183X18823377
Wang G, Tan T, Liu Y, Hong P. Drugs for Acute Attack of Pediatric Migraine A Network Meta-analysis of Randomized Controlled Trials. Clin Neurol Neurosurg 2020; 195:105853. https://doi.org/10.1016/j.clineuro.2020.105853
Negro A, Koverech A, Martelletti P. Serotonin receptor agonists in the acute treatment of migraine a review on their therapeutic potential. J Pain Res 2018; 11:515–26. 10.2147/JPR.S132833
Kempwade AA, Taranalli AD, Hiremath RD, Joshi SA. Formulation and Evaluation of Flexible Liposome Embedded In Situ Thermoreversible Intranasal Gel of Rizatriptan Benzoate. Indian J Pharm Sci 2022; 84(4):863–73. 10.36468/pharmaceutical-sciences.981
Abujbarah SM, Jogerst K, Kosiorek HE, Ahmad S, Cronin PA, Casey W, et al. Postoperative Hematomas in the Era of Outpatient MastectomyIs Ketorolac Really to Blame? Ann Surg Oncol 2022; 29(10):6395–403. https://doi.org/10.1245/s10434-022-12141-8
Babaie S, Taghvimi A, Hong JH, Hamishehkar H, An S, Kim KH. Recent advances in pain management based on nanoparticle technologies. J Nanobiotechnology 2022; 20(1):290. https://doi.org/10.1186/s12951-022-01473-y
Smail SS, Ghareeb MM, Omer HK, Al-Kinani AA, Alany RG. Studies on Surfactants Cosurfactants and Oils for Prospective Use in Formulation of Ketorolac Tromethamine Ophthalmic Nanoemulsions. Pharmaceutics 2021; 13(4):467. https://doi.org/10.3390/pharmaceutics13040467
Ejeta F, Gabriel T, Joseph NM, Belete A. Formulation Optimization and In Vitro Evaluation of Fast Disintegrating Tablets of Salbutamol Sulphate using a Combination of Superdisintegrant and Subliming Agent. Curr Drug Deliv 2022; 19(1):129–41. https://doi.org/10.2174/1567201818666210614094646
RaheemA, Singh R, Hiremath A, Nayak S, KamathS, SK. Formulation and comparative evaluation of ondansetron hydrochloride mouth dissolving tablets in india. Int J Pharm Pharm Sci 2019; 57–64. http://dx.doi.org/10.22159/ijpps.2019v11i9.33840
Goh HP, Heng PW, Liew CV. Understanding die fill variation during minitablet production. Int J Pharm 2017; 534(1–2):279–86. https://doi.org/10.1016/j.ijpharm.2017.10.042
Kumar RS, Yagnesh TN. Synthesis characterization and evaluation of starch xanthate as a superdisintegrant in the formulation of fast dissolving tablets. Int J Appl Pharm. 2018;10(6):249. https://doi.org/10.22159/ijap.2018v10i6.29128
Shinkar DM, Aher PS, Kothawade PD, Maru AD. Formulation and in vitro evaluation of fast dissolving tablet of verapamil hydrochloride. Int J Pharm Pharm Sci 2018; 10(10):93. https://doi.org/10.22159/ijpps.2018v10i10.28714
Zhu C, Lal M. Preclinical Safety and Pharmacokinetics of Heat Stable Oxytocin in Sublingual Fast Dissolving Tablet Formulation. Pharmaceutics 2022; 14(5):953. https://doi.org/10.3390/pharmaceutics14050953
Garg A, Gupta MM. Taste masking and formulation developement &evaluation of mouth dissolving tablets of levocetrizine dihydrochloride. J Drug Deliv Ther 2013; 3(3):123–30. https://doi.org/10.22270/jddt.v3i3.514
Aslani A, Beigi M. Design formulation and physicochemical evaluation of montelukast orally disintegrating tablet. Int J Prev Med. 2016; 7(1):120. 10.4103/2008-7802.193097
Vlad RA, Antonoaea P, Todoran N, Rédai EM, Bîrsan M, Muntean DL, et al. Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 23Factorial Design. Pharmaceutics 2022; 14(7):1467. https://doi.org/10.3390/pharmaceutics14071467
Elsayed MM, Aboelez MO, Elsadek BE, Sarhan HA, Khaled KA, Belal A, et al. Tolmetin Sodium Fast Dissolving Tablets for Rheumatoid Arthritis Treatment Preparation and Optimization Using Box-Behnken Design and Response Surface Methodology. Pharmaceutics 2022; 14(4):880. https://doi.org/10.3390/pharmaceutics14040880
Carpenter A, Gupta MK, Jain NK, Sharma U, Sisodiya R. Formulation and development of fast dissolving tablet of metoclopramide an antiemetic drug. J Biomed Pharm Res 2019; 8(6). https://doi.org/10.32553/jbpr.v8i6.699
Nagar PK. SUPERDISINTEGRANTSCURRENT APPROACH. J Drug Deliv Ther 2014; 4(3):37–44. https://doi.org/10.22270/jddt.v4i3.831
Oraeluno JN, Obasi JC, Bamigbola EA, Joseph BA.Production and Evaluation of Disintegrant Properties of Microcrystalline Cellulose Derived from Saccharum officinarum L (Poaceae) in Metronidazole Based Formulation. Int J Pharm Sci Med 2021; 6(4):42–51. 10.47760/ijpsm. 2021.v06i04.004
Pawar P, Bala R, Khanna S. Formulation and optimization of fast dissolving intraoral drug delivery system for clobazam using response surface methodology. J Adv Pharm Technol Res 2013; 4(3):151. 10.4103/2231-4040.116785
Pabari RM, Ramtoola Z. Effect of a Disintegration Mechanism on Wetting Water Absorption and Disintegration Time of Orodispersible Tablets. J Young Pharm 2012; 4(3):157–63. https://doi.org/10.4103/0975-1483.100021
Kuck J, Breitkreutz J. Impact of Lubrication on Key Properties of Orodispersible Minitablets in Comparison to Conventionally Sized Orodispersible Tablets. Eur J Pharm Biopharm. 2022; S0939641122001898. https://doi.org/10.1016/j.ejpb.2022.08.023
Bele MH, Derle DV. Mechanism of disintegrant action of polacrillin potassium Swelling or wicking? Acta Pharm Sin B 2012; 2(1):70–6. https://doi.org/10.1016/j.apsb.2011.12.002
Bhardwaj S, Jain V, Jat RC, Mangal A, Jain S. Formulation and evaluation of fast dissolving tablet of aceclofenac. Int J Drug Deliv 2010; 2(1):93–7. 10.5138/ijdd.2010.0975.0215.02017
Thoorens G, Krier F, Leclercq B, Carlin B, Evrard B. Microcrystalline cellulose a direct compression binder in a quality by design environment A review. Int J Pharm 2014; 473(1–2):64–72. https://doi.org/10.1016/j.ijpharm.2014.06.055
Yang B, Wei C, Yang Y, Wang Q, Li S. Evaluation about wettability water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration. Drug Dev Ind Pharm 2018; 44(9):1417–25. https://doi.org/10.1080/03639045.2018.1453519
Postek E, Sadowski T. Assessing the Influence of Porosity in the Deformation of Metal. Ceramic Composites. Compos Interfaces 2011; 18(1):57–76.
Ohrem HL, Schornick E, Kalivoda A, Ognibene R. Why is mannitol becoming more and more popular as a pharmaceutical excipient in solid dosage forms? Pharm Dev Technol 2014; 19(3):257–62. https://doi.org/10.3109/10837450.2013.775154
Lourenco C, Keny R, Desouza C. Formulation and evaluation of rizatriptan Benzoate mouth disintegrating tablets. Indian J Pharm Sci 2010; 72(1):79. 10.4103/0250-474X.62253
Raina B, Sharma A, Bajwa PS. Formulation evaluation and optimization of fast disintegrating tablets of ketorolac tromethamine. J Pharm Investig 2018; 48(6):685–95. https://doi.org/10.1007/s40005-017-0366-0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Rawand Sirwan Izzalddin, Nozad Rashid Hussein (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in Zanco J Med Sci is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).
